nedelja, 8. april 2018

Mental health care reform in Macedonia: a good practice that turned into a bad example




Care for persons with mental health conditions is mainly provided in public psychiatric wards, although care from private providers is also available. The public system is represented by the Specialised Psychiatric Hospitals and the University Clinic of Psychiatry with inpatient and day care services, both located in the capital Skopje, and several day centres for mental health care, prevention and treatment of depression located within the Health Centres.

The mental health reform was in line with the strategic determination in social protection is for deinstitutionalisation, towards community-oriented service delivery in line with the EU strategy (Ministry of Labour and Social Policy, 2008) and then adopted WHO European Mental Health Action Plan. Activities were pursued accordingly; in cooperation with WHO and the Council of Europe, the aim was to develop socially oriented psychiatry and to set up more mental health centres in the community, taking local needs into account. However, a World Bank loan was used to perform reconstruction works on the psychiatric hospitals in Skopje and Negorci, which is not in line with deinstitutionalisation and gives a wrong message to the actors involved.

In 2006, the Law on Mental Health was enacted, regulating the rights and responsibilities of both health care providers and persons with mental health conditions. Due to the importance of mental health in the community, the law also provides legal grounds for establishing a Mental Health Committee in each unit of local government, enabling close monitoring of the implementation and protection of the rights of the persons with mental conditions. In very few cases, municipalities have established such committees; however, their work is not publicised or widely disseminated to the public. For many years, the country has had an annual public health programme for mental health that mainly comprised of providing education to the population, and adolescents in particular, as well as counselling persons with severe mental health conditions including suicidal intentions among the young (Milevska Kostova et al., 2017).

Health care for persons with mental health problems is provided on three conventional levels: primary, secondary and tertiary. Primary health care physicians are the first contact between the patient and the health system and they serve as gatekeepers to detect the problem and refer patients to higher levels of health care. Secondary health care is provided by the neuropsychiatry consultative-specialist outpatient services that function within the Health Centres throughout the country, as well as the Institutes for Children and Youth in Skopje and Bitola. Neuropsychiatry wards within 13 Medical Centres throughout the country provide in-patient secondary care (wards provide hospitalisation of both neurological and psychiatric patients; in general, most patients suffer from neurological disorders).  The tertiary level is represented with three specialist psychiatric hospitals: Psychiatric hospital Bardovci (Skopje), Psychiatric hospital Demir Hisar and Psychiatric hospital Negorci, which have been and still are mainly providing care for patients with mental health problems. Patients are hospitalised on a principle of residing in the respective region. Additional tertiary inpatient mental health care is provided by the University Clinic of Psychiatry and Neuropsychiatry ward in the City General Hospital ‘8 Septemvri’ in Skopje (WHO, 2009).

The reforms of the Ministry of Health created the foundation for the Mental Health Project of WHO, Country Office Skopje, which has created several community mental health services since 2000. Seven Community Mental Health Centres (CMHC) have been established in various parts of the country: Prolet, Idadija and Vlae in Skopje, in Prilep, in Tetovo, Strumica and in Gevgelija. WHO Country Office in Skopje has provided the training for the multi-disciplinary teams working in the CMHCs (WHO, 2009).

The focus was on changing the approach in the treatment towards psychiatry oriented in the community, not only in the forms of providing care but also in the essence of the content of the care. Particular attention was paid to the reintegration of the patients in the community.

The psychosocial approach for successful integration of the users in the community was supported by establishing Social clubs within the CMHCs, where different skills training, family interventions, self-help groups were organised. In addition, the protected living arrangements were promoted as alternative to long-term hospitalisation.

This reform process was further developed by establishing social firms where people with mental health issues had the possibilities to be employed according the Law on Employment of persons with Disabilities. But, with the changes of the Law in 2005, people with mental health issues were no longer eligible as employees according the Law, which led to closure of the social firms. 

WHO supported the reform, it was well planned and implemented, but it was not sustainable. While WHO was implementing the process (there was an agreement with MoH), the services were functioning in a good manner, but once the project finished, the Government lost the interest –resulting in closure of few services. Somehow, there was lack of attention, resources and political will to continue with the action plan. Also, the resistance to change (closure of the hospitals especially) by the staff (medical personnel) was emphasised that significantly obstructed the process. Once a successful process, now it is an example of the opposite.  At this point, there is an ongoing initiative to re-establish the National group on mental health that will work on the new mental health strategy.

Claimer: This blog is intended as a part of Situation Analysis and Assessment/ Evaluation Report of Implementation of National Strategy on Deinstitutionalisation 2008–2018, which will be soon presented to the public within the EU framework project Technical assistance support for the deinstitutionalization process in social sector. For this blog, Vlado Krstovski is considered to be co-author.



References:

Milevska Kostova, N., Chichevalieva, S., Ponce, N.A., van Ginneken, E., Winkelmann, J. (2017) ‘The former Yugoslav Republic of Macedonia: Health system review’. Health Systems in Transition, 2017; 19(3):1–160. http://www.euro.who.int/__data/assets/pdf_file/0006/338955/Macedonia-HiT-web.pdf?ua=1

Republika Makedonija (2005) Nacionalna strategija za unapreduvanje na mentalnoto zdravje vo Republika Makedonija.

2005/2012 (National Strategy on Promotion of Mental Health in the Republic of Macedonia 2005/2012).

WHO-AIMS (2009) Report on Mental Health System in The former Yugoslav Republic  of  Macedonia. Skopje: WHO  and  Ministry  of  Health.


32 komentarjev:

  1. Nice post! This is a very nice blog that I will definitively come back to more times this year! Thanks for informative post. Wholesale Diabetic Test Strips Kinderkleding online

    OdgovoriIzbriši
  2. Are you tired of seeking loans and Mortgages, have you been turned down constantly By your banks and other financial institutions,We offer any form of loan to individuals and corporate bodies at low interest rate. If you are interested in taking a loan, feel free to contact us today, We promise to offer you the best services ever. Just give us a try, because a trial will convince you.What are your Financial needs?Do you need a business loan?Do you need a personal loan?Do you want to buy a car?Do you want to refinance?Do you need a mortgage loan?Do you need a huge capital to start off your business proposal or expansion? Have you lost hope and you think there is no way out, and your financial burdens still persists? Contact us (infoloanfirm8@gmail.com)

    OdgovoriIzbriši
  3. Thanks a lot for sharing this amazing knowledge with us. This site is fantastic. I always find great knowledge from it. Virginia Group Home Consultant

    OdgovoriIzbriši
  4. Thanks for Sharing
    Find one of the leading Telehealth services for Mental Health in America, USA. I.e. ZohRx Solutions. We are the top Telehealth service for Mental Health Providers in America USA Online.

    OdgovoriIzbriši
  5. thanks for sharing this blog. Our portal is also used by the Neuro Franchise Company & Third Party Neuro PCD Manufacturing companies to invites
    Neuro PCD company products supplier to get Neuro Pcd Pharma Companies opportunity in pan India level locations. Neuropsychiatry Product Range of Neuro medicine company provide is Anti Depressants, Anti Psychotics , Anti Epileptic, Antispasmodic Products, Anti-Addiction Range, Anxiolytics Medicines, Anti Allergic Range PCD etc. we are also serving for Neuro Pharma Franchise Company business opportunity.

    OdgovoriIzbriši
  6. thanks for sharing this blog. I appreciate your good work.
    PCD Dermatology Companies Providing Derma Products PCD Companies & Third Party Manufacturing in India. www.dermamedicinecompany.com is an online B2B Portal. We provide quality skincare products and top dermatology pharmaceutical companies in India. Our Derma PCD Pharma Companies model comes as a composite package which offers our franchisees in form of Relationship with Care, Quality and people in the monopoly based Pharma Franchise Company for Derma Medicine.

    OdgovoriIzbriši
  7. Truly useful tips. You just can’t write anything and expect readers to follow back. Blog commenting is all about building the relationship with the other bloggers in your niche and leaving something valuable in order to attract quality readers. get in touch with us:- PCD Pharma Companies in Dermatology

    OdgovoriIzbriši
  8. Thanks for sharing this wonderful article! With the covid-19 pandemic entering into its second year, the mental health of our work-from-home employees is taking a serious toll. So here we comes up Corporate Mental Health Programme To help corporates overcome the mental health crisis.

    OdgovoriIzbriši
  9. These are some great tools that i definitely use for SEO work. This is a great list to use in the future.. more info

    OdgovoriIzbriši
  10. BUSINESS LOAN PERSONAL LOAN HERE APPLY NOW WhatsApp No:+918929509036 financialserviceoffer876@gmail.com Dr. James Eric

    OdgovoriIzbriši
  11. I appreciate you revealing this blog. I value the quality of your work.

    OdgovoriIzbriši
  12. We appreciate you sharing this wonderful data among us.
    Mental Health in the Workplace

    OdgovoriIzbriši
  13. You add interest as well as participation to this content. I value that style of blogging.

    Mental Well being at the Workplace

    OdgovoriIzbriši
  14. Good Article...! This approach not only helps reduce the stigma associated with seeking Telehealth for mental health assistance but also ensures that individuals receive the necessary support in familiar surroundings.

    OdgovoriIzbriši
  15. Nice article .. If you are struggling with any mental health issues visit near by spravato treatment center to overcome it

    OdgovoriIzbriši
  16. Thank you for posting this helpful blog, and we also focused on the development and marketing of high quality, specialist generic medicines across the UK, Europe, ANZ, Canada, US and globally. For more information, visit at pharma business

    OdgovoriIzbriši
  17. Hi there! Good post! Please let us know as soon as there is a follow-up!
    pharma medicines
    pharma industry uk
    our pharma
    syri ltd
    orbit career

    OdgovoriIzbriši
  18. Great article! Orbital Pharma has been focusing heavily on small molecule drug development as well. Recently, we’ve achieved significant breakthroughs in targeting specific disease pathways, which have shown promising results in our clinical trials. If anyone is interested in learning more about our latest advancements, feel free to check out our website Orbital Pharma. We also share regular updates on our research and development on our social media channels. Looking forward to more insightful articles on this topic!

    OdgovoriIzbriši
  19. "Pharma development is a critical aspect of healthcare, driving innovation and improving patient outcomes. The process, however, is complex and multifaceted, involving rigorous stages from drug discovery to clinical trials and regulatory approval. What excites me most is the increasing integration of cutting-edge technologies like AI and machine learning in streamlining drug development. These advancements are not only accelerating timelines but also improving the accuracy of predicting drug efficacy and safety. It's fascinating to witness how personalized medicine is becoming a reality, thanks to these technological breakthroughs. I'm looking forward to seeing how the industry continues to evolve and address the challenges, particularly in making life-saving drugs more accessible and affordable worldwide."

    OdgovoriIzbriši
  20. "Pharma medicines have significantly evolved over the years, offering more effective treatments and improved patient outcomes. It's fascinating to see how ongoing research and development in the pharmaceutical industry continue to bring innovative solutions to market. How do you think the future of pharma medicines will shape global healthcare, especially in terms of accessibility and affordability?"

    OdgovoriIzbriši
  21. Orbits UK is at the forefront of pharmaceutical innovation, offering cutting-edge solutions that cater to the evolving needs of the healthcare sector. With a strong commitment to quality and research, Orbits UK has developed a range of products and services that are shaping the future of medicine.

    OdgovoriIzbriši
  22. "Company Pharma has consistently demonstrated its commitment to innovation and patient care, making significant strides in the pharmaceutical industry. Their focus on research and development has resulted in groundbreaking therapies that address unmet medical needs. I'm particularly impressed by their recent advancements in [specific area, e.g., oncology, rare diseases, etc.], which underscore their leadership in the field. It's encouraging to see companies like this driving progress and improving patient outcomes. Looking forward to more updates and insights from Company Pharma."

    OdgovoriIzbriši
  23. "Thank you for this insightful post on the latest trends in pharma medicines! It's fascinating to see how advancements in drug development are transforming patient care. The emergence of personalized medicine, particularly in oncology, is a game-changer, providing treatments tailored to individual genetic profiles. However, with these innovations, there are also challenges, especially regarding regulatory approval and ensuring equitable access to these cutting-edge therapies.

    I'd love to hear more about how the industry is addressing these challenges, particularly in terms of pricing and availability in developing countries. Ensuring that life-saving medicines reach all who need them is crucial, and I'm curious about the strategies pharma companies are employing to balance innovation with accessibility.

    OdgovoriIzbriši
  24. The pharma industry uk continues to play a pivotal role in global healthcare innovation, especially with its strong research and development sector. The post brilliantly captures how UK-based pharma companies are pushing boundaries with new drug discoveries, despite challenges like regulatory hurdles and pricing pressures.

    One aspect that stands out is the sector’s resilience post-Brexit, where the focus on collaboration with international markets has been crucial in maintaining growth. Additionally, the strong support from the UK government in terms of R&D tax credits and grants is encouraging further advancements.

    Looking forward, it will be interesting to see how the industry continues to evolve with the growing role of biopharma and emerging technologies like AI in drug development.

    OdgovoriIzbriši
  25. Syri Ltd has been at the forefront of technological advancements, providing innovative solutions that drive efficiency and growth across various sectors. Their commitment to quality and customer satisfaction sets them apart in a competitive landscape.

    OdgovoriIzbriši